REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer

Castration-resistance prostate cancer (CRPC), also known as hormone-refractory prostate cancer (HRPC), requires immediate attention since it is not only resistant to androgen ablation, chemo- and radiotherapy, but also highly metastatic. Increasing evidence suggests that enrichment of neuroendocrine...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yi-Ting, Lin, Tzu-Ping, Campbell, Mel, Pan, Chin-Chen, Lee, Shu-Hui, Lee, Hsin-Chen, Yang, Muh-Hwa, Kung, Hsing-Jien, Chang, Pei-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335619/
https://www.ncbi.nlm.nih.gov/pubmed/28256535
http://dx.doi.org/10.1038/srep42795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335619/
https://www.ncbi.nlm.nih.gov/pubmed/28256535
http://dx.doi.org/10.1038/srep42795

Ejemplares similares